CM
CM Management Portfolio holdings
AUM
$110M
1-Year Return
9.76%
This Quarter Return
-1.99%
1 Year Return
+9.76%
3 Year Return
+99.54%
5 Year Return
–
10 Year Return
–
AUM
$119M
AUM Growth
-$13.3M
(-10%)
Cap. Flow
-$4.74M
Cap. Flow
% of AUM
-3.98%
Top 10 Holdings %
Top 10 Hldgs %
39.21%
Holding
91
New
3
Increased
43
Reduced
6
Closed
20
Top Buys
| 1 |
WBA
Walgreens Boots Alliance
WBA
|
$1.79M |
| 2 |
B
Barrick Mining Corporation
B
|
$1.35M |
| 3 |
EXE
Expand Energy Corporation Common Stock
EXE
|
$1.31M |
| 4 |
Kyndryl
KD
|
$1.18M |
| 5 |
Heron Therapeutics
HRTX
|
$858K |
Top Sells
| 1 |
Coterra Energy
CTRA
|
$3.04M |
| 2 |
Cytokinetics
CYTK
|
$2.02M |
| 3 |
Kinder Morgan
KMI
|
$1.98M |
| 4 |
First Financial Corporation Common Stock
THFF
|
$1.81M |
| 5 |
CVS Health
CVS
|
$1.55M |
Sector Composition
| 1 | Healthcare | 37.33% |
| 2 | Energy | 14.56% |
| 3 | Financials | 10.58% |
| 4 | Materials | 8.62% |
| 5 | Technology | 7.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
USAP
51
DELISTED
Universal Stainless & Alloy
USAP
| $781K | 0.66% |
90,000
| – | – |
|
|
SPPI
52
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
| $774K | 0.65% |
600,000
+450,000
| +300% | +$581K |
|
53
ARKO Corp Warrant
ARKOW
$1.43M
| $760K | 0.64% |
400,000
+100,000
| +33% | +$190K |
|
54
BioCardia
BCDA
$11.8M
| $681K | 0.57% |
21,933
| – | – |
|
55
Garrett Motion
GTX
$2.66B
| $647K | 0.54% |
90,000
| – | – |
|
56
AMCON Distributing
DIT
$75.5M
| $621K | 0.52% |
4,000
| – | – |
|
57
Cartesian Therapeutics
RNAC
$260M
| $615K | 0.52% |
16,667
+3,334
| +25% | +$123K |
|
|
NBSE
58
DELISTED
NeuBase Therapeutics, Inc. Common Stock
NBSE
| $611K | 0.51% |
16,250
+8,750
| +117% | +$329K |
|
59
Smith Micro Software
SMSI
$15.3M
| $603K | 0.51% |
20,000
| – | – |
|
60
inTEST
INTT
$88.8M
| $590K | 0.5% |
55,000
+35,000
| +175% | +$375K |
|
61
Gain Therapeutics
GANX
$62.6M
| $511K | 0.43% |
125,000
+35,000
| +39% | +$143K |
|
62
Femasys
FEMY
$12M
| $509K | 0.43% |
225,000
+125,000
| +125% | +$283K |
|
|
BCEL
63
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
| $476K | 0.4% |
150,000
+85,000
| +131% | +$270K |
|
|
CBAY
64
DELISTED
Cymabay Therapeutics
CBAY
| $467K | 0.39% |
150,000
| – | – |
|
|
SVC
65
Service Properties Trust
SVC
$462M
| $442K | 0.37% |
50,000
+25,000
| +100% | +$221K |
|
66
Newell Brands
NWL
$2.64B
| $428K | 0.36% |
20,000
+10,000
| +100% | +$214K |
|
67
Compass Therapeutics
CMPX
$578M
| $411K | 0.35% |
+300,000
| New | +$411K |
|
68
Relmada Therapeutics
RLMD
$45.5M
| $405K | 0.34% |
15,000
+5,000
| +50% | +$135K |
|
69
Nektar Therapeutics
NKTR
$684M
| $404K | 0.34% |
5,000
+3,333
| +200% | +$269K |
|
70
Aterian
ATER
$9.51M
| $243K | 0.2% |
8,333
+2,083
| +33% | +$60.7K |
|
71
Lantern Pharma
LTRN
$45.4M
| $241K | 0.2% |
+33,765
| New | +$241K |
|
72
ACNB Corp
ACNB
$476M
| – | – |
-35,000
| Closed | -$1.1M |
|
73
Agnico Eagle Mines
AEM
$74.5B
| – | – |
-20,000
| Closed | -$1.06M |
|
74
Bristol-Myers Squibb
BMY
$95B
| – | – |
-15,000
| Closed | -$935K |
|
|
75
Coterra Energy
CTRA
$18.6B
| – | – |
-160,000
| Closed | -$3.04M |
|